Claims
- 1. A compound of the formula: ##STR104## and the physiologically acceptable salts thereof, wherein n is 2 or 3;
- R.sub.3 and R.sub.4 are lower alkyl,
- R.sub.1 and R.sub.2 together with the nitrogen to which they are attached, represent a heterocyclic group selected from the group consisting of pyrrolidino, morpholino or piperidino, and
- wherein HALO is chloro or bromo.
- 2. The compound of claim 1 wherein n is 2.
- 3. The compound of claim 1 wherein HALO is chloro.
- 4. The compound of claim 1 which is selected from the group consisting of 2,4-dimethoxy-5-chloro-N-(2-N-pyrrolidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-piperidinyl ethyl)benzenesulfnamide; 2,4-dimethoxy-5-chloro-N-(2-N-morpholinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-piperidinyl propyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-morpholinyl propyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-pyrolidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-piperidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-morpholinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-piperidinylpropyl)benzenesulfonamide; 2,4-N-dimethoxy-5-bromo-N-(2-N-morpholinyl-propyl)benzenesulfonamide.
- 5. The compound of claim 4 which is selected from the group consisting of 2,4-dimethoxy-5-chloro-N-(2-N-pyrrolidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-piperidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-morpholinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-pyrrolidinyl ethyl)benzenesulfonamide and 2,4-dimethoxy-5-bromo-N-(2-N-piperidinyl ethyl)benzenesulfonamide.
- 6. A pharmaceutical composition which comprises a pharmaceutical carrier and a phenobarbital sleep potentiating effective amount of a compound of the formula: ##STR105## and the physiologically acceptable salts thereof, wherein n is 2 or 3;
- R.sub.3 and R.sub.4 are lower alkyl;
- R.sub.1 and R.sub.2 together with the nitrogen to which they are attached, represent a heterocyclic group selected from the group consisting of pyrrolidino, morpholino, or piperidino; and wherein
- HALO is chloro or bromo.
- 7. The pharmaceutical composition of claim 6 wherein n is 2.
- 8. The pharmaceutical composition of claim 6 wherein HALO is chloro.
- 9. The pharmaceutical composition of claim 6 wherein the compound is selected from the group consisting of 2,4-dimethoxy-5-chloro-N-(2-N-pyrrolidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-piperidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-morpholinyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-piperidinyl propyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-morpholinyl propyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-pyrrolidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-piperidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-morpholinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-piperidinyl propyl)benzenesulfonamide; 2,4-N-dimethoxy-5-bromo-N-(2-N-morpholinyl-propyl)benzenesulfonamide.
- 10. The pharmaceutical composition of claim 9 wherein the compound is selected from the group consisting of 2,4-dimethoxy-5-chloro-N-(2-N-pyrrolidinyl ethyl)benzenesulfoanamide; 2,4 dimethoxy-5-chloro-N-(2-N-piperidinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-chloro-N-(2-N-morpholinyl ethyl)benzenesulfonamide; 2,4-dimethoxy-5-bromo-N-(2-N-pyrrolidinyl ethyl)benzenesulfonamide and 2,4-dimethoxy-5-bromo-N-(2-N-piperidinyl ethyl)benzenesulfonamide.
Parent Case Info
This application is a division of application Ser. No. 370,168, filed Apr. 20, 1982.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4132786 |
Moreau et al. |
Jan 1979 |
|
Non-Patent Literature Citations (1)
Entry |
Fournier et al, Chemical Abstracts, vol. 98 (1983), No. 178939z. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
370168 |
Apr 1982 |
|